2007
DOI: 10.1016/j.aca.2007.04.043
|View full text |Cite
|
Sign up to set email alerts
|

Assessing the statistical validity of proteomics based biomarkers

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
151
0

Year Published

2008
2008
2016
2016

Publication Types

Select...
7
1
1

Relationship

3
6

Authors

Journals

citations
Cited by 166 publications
(157 citation statements)
references
References 15 publications
1
151
0
Order By: Relevance
“…PLSDA was used to discriminate between the two groups. 25 cross model validations [Anderssen et al (2006)] or sometimes called double cross validation [Smit et al (2007)] were performed. In each double cross validation the samples were divided into seven groups.…”
Section: Dmentioning
confidence: 99%
“…PLSDA was used to discriminate between the two groups. 25 cross model validations [Anderssen et al (2006)] or sometimes called double cross validation [Smit et al (2007)] were performed. In each double cross validation the samples were divided into seven groups.…”
Section: Dmentioning
confidence: 99%
“…In the first analysis, multiple linear regression analysis with forward stepwise variable selection was performed within a double-cross validation scheme with 7-fold single-cross validation and 8-fold double-cross validation (Smit et al, 2007) (inhouse written routine available on request). The analysis was repeated 30 times with different assignments of samples into validation, calibration, and test sets.…”
Section: Added Value Of Metabolomics Analysismentioning
confidence: 99%
“…Other model validation techniques commonly employed include Leave one out cross validation or up to 10-fold cross validation [60,61]. Pérez-Guaita et al [62] more recently evaluated the use of permutation testing, commonly used in metabolomics [63] and proteomics [64], which employs a random reallocation of class labels in order to establish the statistical significance of a cross-validation figure of merit of a classifier. Ultimately, however, the validation of the integrated techniques of spectroscopy and multivariate classifiers will have to comply with the rigours of the clinical environment, including large scale blind datasets and randomised trials [1].…”
Section: Discussionmentioning
confidence: 99%